These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 15177663

  • 1. Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer.
    Neuhaus T, Ko YD, Lorenzen K, Fronhoffs S, Harth V, Bröde P, Vetter H, Bolt HM, Pesch B, Brüning T.
    Toxicol Lett; 2004 Jun 15; 151(1):273-82. PubMed ID: 15177663
    [Abstract] [Full Text] [Related]

  • 2. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
    Ruwali M, Khan AJ, Shah PP, Singh AP, Pant MC, Parmar D.
    Environ Mol Mutagen; 2009 Jul 15; 50(6):473-82. PubMed ID: 19334053
    [Abstract] [Full Text] [Related]

  • 3. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J, De Ruyck K, Duprez F, Van Eijkeren M, Rietzschel E, Bekaert S, Vral A, De Neve W, Thierens H.
    Mutat Res; 2008 Oct 30; 656(1-2):74-81. PubMed ID: 18768166
    [Abstract] [Full Text] [Related]

  • 4. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
    Olivieri EH, da Silva SD, Mendonça FF, Urata YN, Vidal DO, Faria Mde A, Nishimoto IN, Rainho CA, Kowalski LP, Rogatto SR.
    Oral Oncol; 2009 Sep 30; 45(9):e73-9. PubMed ID: 19442564
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC, Ribeiro DC, Gomez MV, Ramos-Jorge ML, Gomez RS.
    Anticancer Res; 2008 Sep 30; 28(2A):1101-6. PubMed ID: 18507060
    [Abstract] [Full Text] [Related]

  • 6. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.
    Harth V, Schafer M, Abel J, Maintz L, Neuhaus T, Besuden M, Primke R, Wilkesmann A, Thier R, Vetter H, Ko YD, Bruning T, Bolt HM, Ickstadt K.
    J Toxicol Environ Health A; 2008 Sep 30; 71(13-14):887-97. PubMed ID: 18569591
    [Abstract] [Full Text] [Related]

  • 7. Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese.
    Gao C, Takezaki T, Wu J, Li Z, Wang J, Ding J, Liu Y, Hu X, Xu T, Tajima K, Sugimura H.
    Cancer Epidemiol Biomarkers Prev; 2002 Jan 30; 11(1):29-34. PubMed ID: 11815398
    [Abstract] [Full Text] [Related]

  • 8. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
    Singh AP, Shah PP, Ruwali M, Mathur N, Pant MC, Parmar D.
    Cancer Invest; 2009 Oct 30; 27(8):869-76. PubMed ID: 19639480
    [Abstract] [Full Text] [Related]

  • 9. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer.
    Gattás GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, Eluf-Neto J, Wünsch-Filho V.
    Head Neck; 2006 Sep 30; 28(9):819-26. PubMed ID: 16721740
    [Abstract] [Full Text] [Related]

  • 10. Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease.
    Arif E, Vibhuti A, Alam P, Deepak D, Singh B, Athar M, Pasha MA.
    Clin Chim Acta; 2007 Jul 30; 382(1-2):37-42. PubMed ID: 17442289
    [Abstract] [Full Text] [Related]

  • 11. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D.
    Mutat Res; 2008 Feb 01; 638(1-2):184-94. PubMed ID: 18035380
    [Abstract] [Full Text] [Related]

  • 12. [Correlation of prostate cancer susceptibility with genetic polymorphism of cytochrome P450 2E1, smoking and drinking: a case-control study in the population of Nanjing area].
    Yang J, Gu M, Song NH, Feng NH, Hua LX, Ju XB, Sui YG, Wang XR, Wu HF.
    Zhonghua Nan Ke Xue; 2009 Jan 01; 15(1):7-11. PubMed ID: 19288740
    [Abstract] [Full Text] [Related]

  • 13. Polymorphisms in genes coding for enzymes metabolizing smoking-derived substances and the risk of periodontitis.
    Kim JS, Park JY, Chung WY, Choi MA, Cho KS, Park KK.
    J Clin Periodontol; 2004 Nov 01; 31(11):959-64. PubMed ID: 15491310
    [Abstract] [Full Text] [Related]

  • 14. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P.
    Anticancer Res; 2004 Nov 01; 24(3b):2021-6. PubMed ID: 15274394
    [Abstract] [Full Text] [Related]

  • 15. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
    Wu SH, Tsai SM, Hou MF, Lin HS, Hou LA, Ma H, Lin JT, Yeh FL, Tsai LY.
    Breast Cancer Res Treat; 2006 Nov 01; 100(1):93-8. PubMed ID: 16758119
    [Abstract] [Full Text] [Related]

  • 16. Association of CYP2E1 gene polymorphism with predisposition to cancer development.
    Danko IM, Chaschin NA.
    Exp Oncol; 2005 Dec 01; 27(4):248-56. PubMed ID: 16404342
    [Abstract] [Full Text] [Related]

  • 17. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
    Morita M, Le Marchand L, Kono S, Yin G, Toyomura K, Nagano J, Mizoue T, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Imaizumi N.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 01; 18(1):235-41. PubMed ID: 19124503
    [Abstract] [Full Text] [Related]

  • 18. Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study.
    Ickstadt K, Schäfer M, Fritsch A, Schwender H, Abel J, Bolt HM, Brüning T, Ko YD, Vetter H, Harth V.
    J Toxicol Environ Health A; 2008 Jan 01; 71(11-12):803-15. PubMed ID: 18569579
    [Abstract] [Full Text] [Related]

  • 19. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P, Khantapura P.
    Oral Oncol; 2006 Mar 01; 42(3):257-67. PubMed ID: 16275157
    [Abstract] [Full Text] [Related]

  • 20. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
    Asefi V, Mojtahedi Z, Khademi B, Naeimi S, Ghaderi A.
    J Laryngol Otol; 2009 Apr 01; 123(4):444-8. PubMed ID: 18940019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.